137 related articles for article (PubMed ID: 1331831)
1. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
Grau E; Sigüenza F; Maduell F; Linares M; Olaso MA; Martinez R; Caridad A
Nephron; 1992; 62(1):13-7. PubMed ID: 1331831
[TBL] [Abstract][Full Text] [Related]
2. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
[TBL] [Abstract][Full Text] [Related]
3. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J
Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.
Shinoda T; Arakura H; Katakura M; Shirota T; Nakagawa S
Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970
[TBL] [Abstract][Full Text] [Related]
5. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
[TBL] [Abstract][Full Text] [Related]
6. Use of low-dose low molecular weight heparin in hemodialysis.
Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
[TBL] [Abstract][Full Text] [Related]
7. Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (Fraxiparine) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216.
Diéval J; Morinière P; Gross S; d'Azemar P; Fournier A; Delobel J
Thromb Res; 1990 Jun; 58(6):555-60. PubMed ID: 2166971
[TBL] [Abstract][Full Text] [Related]
8. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters.
Ulbricht K; Bucha E; Pöschel KA; Stein G; Wolf G; Nowak G
Clin Nephrol; 2006 Mar; 65(3):180-90. PubMed ID: 16550749
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
Morinière P; Dieval J; Bayrou B; Roussel B; Renaud H; Fournier A; Delobel J
Blood Purif; 1989; 7(6):301-8. PubMed ID: 2558691
[TBL] [Abstract][Full Text] [Related]
10. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
11. Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.
Reach I; Luong N; Chastang C; Chakroun M; Mirshahi S; Mirshahi MC; Soria J; Desmichels D; Baumelou A
Artif Organs; 2001 Jul; 25(7):591-5. PubMed ID: 11493282
[TBL] [Abstract][Full Text] [Related]
12. Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.
Al-Saran KA; Sabry A; Taha M; Ghafour MA; Al Fawzan F
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):43-9. PubMed ID: 20061691
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin in haemodialysis and haemofiltration--comparison with unfractioned heparin.
Renaud H; Moriniere P; Dieval J; Abdull-Massih Z; Dkhissi H; Toutlemonde F; Delobel J; Fournier A
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():276-80. PubMed ID: 3991511
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
Ireland H; Lane DA; Flynn A; Pegrum AC; Curtis JR
Thromb Haemost; 1988 Apr; 59(2):240-7. PubMed ID: 2838924
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose heparin in hemodialysis.
Murea M; Russell GB; Daeihagh P; Saran AM; Pandya K; Cabrera M; Burkart JM; Freedman BI
Hemodial Int; 2018 Jan; 22(1):74-81. PubMed ID: 28418614
[TBL] [Abstract][Full Text] [Related]
17. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study.
Kessler M; Gangemi C; Gutierrez Martones A; Lacombe JL; Krier-Coudert MJ; Galland R; Kielstein JT; Moureau F; Loughraieb N
Hemodial Int; 2013 Apr; 17(2):282-93. PubMed ID: 22925178
[TBL] [Abstract][Full Text] [Related]
18. Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.
Hainer JW; Sherrard DJ; Swan SK; Barrett JS; Assaid CA; Fossler MJ; Cox DS; Williams RM; Pittenger AL; Stephenson CA; Hua TA
Am J Kidney Dis; 2002 Sep; 40(3):531-8. PubMed ID: 12200805
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies.
Chiasakul T; Mullier F; Lecompte T; Nguyen P; Cuker A
Semin Nephrol; 2023 Nov; 43(6):151477. PubMed ID: 38290962
[TBL] [Abstract][Full Text] [Related]
20. Use of single dose low-molecular-weight heparin in long hemodialysis.
Lai KN; Ho K; Li M; Szeto CC
Int J Artif Organs; 1998 Apr; 21(4):196-200. PubMed ID: 9649059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
